These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 10870810)
21. Fibrinogen bellingham: a gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family. Linenberger ML; Kindelan J; Bennett RL; Reiner AP; Côté HC Am J Hematol; 2000 Aug; 64(4):242-50. PubMed ID: 10911375 [TBL] [Abstract][Full Text] [Related]
22. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease. Guédon C; Le Cam-Duchez V; Lalaude O; Ménard JF; Lerebours E; Borg JY Am J Gastroenterol; 2001 May; 96(5):1448-54. PubMed ID: 11374681 [TBL] [Abstract][Full Text] [Related]
23. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism. Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205 [TBL] [Abstract][Full Text] [Related]
30. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism. Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y; Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659 [TBL] [Abstract][Full Text] [Related]
31. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [TBL] [Abstract][Full Text] [Related]
32. Prolonged seated immobility-associated venous coagulability in a factor V Leiden heterozygote: a case-comparative study. Ansari MT; Cheung BM; Karlberg JP Blood Coagul Fibrinolysis; 2006 Apr; 17(3):187-91. PubMed ID: 16575256 [TBL] [Abstract][Full Text] [Related]
33. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I. Terasawa F; Kani S; Hongo M; Okumura N Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498 [TBL] [Abstract][Full Text] [Related]
34. Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Pósán E; Szepesi K; Gáspár L; Csernátony Z; Hársfalvi J; Ajzner E; Tóth A; Udvardy M Blood Coagul Fibrinolysis; 2003 Apr; 14(3):243-8. PubMed ID: 12695746 [TBL] [Abstract][Full Text] [Related]
36. Venous thromboembolism: implications for gene-based diagnosis and technology development. Hooper WC; De Staercke C Expert Rev Mol Diagn; 2002 Nov; 2(6):576-86. PubMed ID: 12465454 [TBL] [Abstract][Full Text] [Related]
37. [Sucessful pregnancy outcome following three severe placental abruptions and intrauterine fetal death in the patient--heterozygous carrier of R506Q mutation of factor V (Leiden)]. Dimitrova V; Koleva R; Savov A; Chernev T; Khranov Iu; Georgiev G; Slŭncheva B; Raĭcheva S Akush Ginekol (Sofiia); 2004; 43(5):47-54. PubMed ID: 15518286 [TBL] [Abstract][Full Text] [Related]
38. Fibrinogen Caracas I: a dysfibrinogenemia with a hemorrhagic diathesis associated with diminished fibrin fiber diameter and reduced fibrin gel porosity. Marchi R; Lundberg U; de Bosch NB; Arocha-Piñango CL Blood Coagul Fibrinolysis; 1998 Nov; 9(8):733-9. PubMed ID: 9890716 [TBL] [Abstract][Full Text] [Related]
39. Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesis. Brenner B; Vulfsons SL; Lanir N; Nahir M Br J Haematol; 1996 Jul; 94(1):166-7. PubMed ID: 8757529 [TBL] [Abstract][Full Text] [Related]